Citi Starts Arsanis Inc. (ASNS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Cowen Starts Arsanis Inc. (ASNS) at Outperform
December 11, 2017 6:14 AM ESTCowen initiates coverage on Arsanis Inc. (NASDAQ: ASNS) with a Outperform rating.
Analyst Ritu Baral sees an excellent chance of success for the ongoing Ph2 of lead drug ASN100 in S. aureus ventilator-associated pneumonia, or VAP (top-line in 2019).
They also believe ASNS'... More
Piper Jaffray Starts Arsanis Inc. (ASNS) at Overweight
December 11, 2017 4:30 AM ESTPiper Jaffray initiates coverage on Arsanis Inc. (NASDAQ: ASNS) with a Overweight rating and a price target of $23.00.
Analyst Ed Tenthoff believes the company has a powerful product in S. Aureus noting is "is a killer in the hospital" and is bullish... More
